In a move set to reshape the landscape of clinical research technology, Thermo Fisher Scientific Inc. announced Wednesday that it will acquire Clario Holdings Inc. from a consortium led by Astorg, Nor...
Thermo Fisher Scientific plans to improve the speed and success of drug development, enabling customers to get medicines to patients faster and more cost effectively Credit: Gorodenkoff/Shutterstock T...
Thermo Fisher partners with OpenAI to accelerate drug development, enhance clinical trials, and optimize biopharma operations with AI technology. Thermo Fisher Scientific Inc. (NYSE:TMO) stock is trad...
